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Whole-genome sequencing across multiple samples in a population provides an unprecedented opportunity for comprehensively
characterizing the polymorphic variants in the population. Although the 1000 Genomes Project (1KGP) has offered brief insights
into the value of population-level sequencing, the low coverage has compromised the ability to confidently detect rare and low-
frequency variants. In addition, the composition of populations in the 1KGP is not complete, despite the fact that the study design
has been extended to more than 2,500 samples from more than 20 population groups. The Malays are one of the Austronesian groups
predominantly present in Southeast Asia andOceania, and the Singapore SequencingMalay Project (SSMP) aims to perform deep whole-
genome sequencing of 100 healthy Malays. By sequencing at a minimum of 303 coverage, we have illustrated the higher sensitivity at
detecting low-frequency and rare variants and the ability to investigate the presence of hotspots of functional mutations. Compared to
the low-pass sequencing in the 1KGP, the deeper coverage allowsmore functional variants to be identified for each person. A comparison
of the fidelity of genotype imputation of Malays indicated that a population-specific reference panel, such as the SSMP, outperforms
a cosmopolitan panel with larger number of individuals for common SNPs. For lower-frequency (<5%) markers, a larger number of indi-
viduals might have to be whole-genome sequenced so that the accuracy currently afforded by the 1KGP can be achieved. The SSMP data
are expected to be the benchmark for evaluating the value of deep population-level sequencing versus low-pass sequencing, especially in
populations that are poorly represented in population-genetics studies.Introduction
Genome-wide association studies (GWASs) have in recent
years successfully identified many variants to be associated
with complex diseases and common traits. This has been
facilitated largely by the SNP database of the International
HapMap Project, which characterized the SNP allele
frequencies and extent of linkage disequilibrium (LD)
between neighboring SNPs present in major population
groups in the world.1–3 SNPs on most commercial arrays
were elected from polymorphism data generated in Euro-
peans, Africans, and East Asians,2,4 and indeed, even the
early-generation genome-wide association arrays5,6 are
already leveraging such information. Additional public
databases for SNPs and copy-number variants (CNVs)
have contributed to the frequency catalog for the known
genetic variants in other diverse populations; one example
is the Singapore Genome Variation Project (SGVP), which
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Singapore.7,8
However, one potential limitation of these databases
appears to be the inadvertent bias toward surveying
common genetic variants appearing at appreciable
frequency (minor allele frequency [MAF] > 5%), and this
bias has left the remaining allelic spectrum unexplored.
Very recent efforts have repeatedly underlined the need
for deep resequencing of the specific population previously
studied with GWAS arrays and subsequent imputation and
reanalysis to allow insights into the contributed and
impact of rarer, protein-changing alleles of higher pene-
trance.9–11
The advent of next-generation-sequencing technologies
has propelled an unbiased discovery of genetic variants
throughout the human genome. Early efforts to provide
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to targeted sequencing of specific genomic regions across
multiple samples12–14 or to whole-genome sequencing of
only one individual at a time.15–20 The 1000 Genomes
Project (1KGP) was among the first efforts to perform
whole-genome sequencing ofmultiple samples in a specific
population and had the eventual goal of sequencing more
than 2,500 individuals from at least 27 human populations
in order to catalog human genetic variants found at
a frequency of 1% or more.21
The pilot phase of the 1KGP involved whole-genome
sequencing at coverages between 23 and 63. Although
this has identified around 8 million SNPs not present in
dbSNP131 from 179 samples, it is likely to have missed
the detection of variants that are private or recurrent but
rare. In this light, several reports have highlighted the
necessity to sequence at higher genome coverage in order
to confidently distinguish low-frequency and rare muta-
tions from sequencing errors in assembly and base
calling,15,18,20 especially in the detection and annotation
of segmental duplications.22 This improvement in the
form of increased coverage has successfully identified
rare, highly penetrant, and pathogenic genetic variants
that have escaped detection by standard GWAS
approaches.9,10
The Singapore Sequencing Malay Project (SSMP) aims to
perform deep, population-level whole-genome sequencing
of 100 healthy Singapore Malays. Malays are an ethnic
group of Austronesian-speaking people predominantly in-
habiting the modern countries of Singapore, Malaysia, and
Indonesia in the Southeast Asian region. Presently, Malays
account for 13.4% of the local population in Singapore
and are broadly defined as comprising descendants of
indigenous Malays residing in Singapore prior to the
British colonization, as well as migrants of other Southeast
Asian Malay ethnic groups, including the Achehnese,
Ambonese, Batak, Bugis, Banarese, Boyanese, Dusun,
Dayak, Iban, Javanese, Kelabit, Kadazan, Minangkabau,
Murut, Makasarese, Melanau, Sumatran, and Sudanese
from Malaysia and Indonesia. A detailed population-
genetics survey of Asian diversity revealed detectable pop-
ulation substructures between these different Malay ethnic
groups,23–25 although, as a whole, the Malays were found
to exhibit a considerable degree of genetic similarity to
the Chinese.7
Here, we describe the genomic resource contributed by
the SSMP; after quality control (QC), 96 Malay samples
from Singapore were sequenced with a minimum of 303
depth coverage. In total, around 14 million SNPs, 1.6
million indels of sizes between 1 and 50 bp, and around
34,000 deletions spanning more than 50 bp were detected.
The high sequencing depth also presented an opportunity
for quantifying the extent of genomic variants that would
be missed by low-pass sequencing and for evaluating the
frequency spectrum of these missed variants. Genomic
hotspots enriched with mutations, particularly those re-
sulting in functional modifications, were also identified.
Loss-of-function (LOF) variants present in the MalayThe Amsamples were also compared to those reported in the
1KGP pilot. Data in the form of the variant call format
(VCF), as well as the phased haplotypes, are publicly avail-
able at the SSMP website (see Web Resources).Material and Methods
Samples
Subjects enrolled in the SSMPwere pseudorandomly selected from
the multiethnic cohort of the Singapore Population Health Study
and consisted of 50 male and 50 female self-reported Malays.
Ethnic membership for each subject was further ascertained by
telephone recall for verification that both sets of grandparents
are self-reported to be Malays. All subjects provided informed
consent to participate in the study. Ethical approval for the orig-
inal Singapore Population Health Study and further ethical
approval for the extension to whole-genome sequencing were
granted by two independent institutional review boards at the
National University Hospital (Singapore) and the National Univer-
sity of Singapore.Sample Preparation and Generation of Sequence Data
Genomic DNA for all 100 individuals was extracted from the
Singapore BioBank and was sent to the Defense Medical and Envi-
ronmental Research Institute for preparation. DNA quantification
was performed with Picogreen, and fluorescence intensity was
measured by the SpectraMax Gemini EM microplate reader with
spectrophotometric settings at 480/520 nm (Ex/Em) for confirm-
ing that DNA concentration was greater than 50 ng/ml. DNA
samples were subsequently delivered to the Illumina facility at
Hayward, CA, USA for whole-genome sequencing with the Illu-
mina HiSeq 2000; the target coverage was 303 for 100 bp
paired-end reads, and the target insert size was 300–400 bp. Prior
to library preparation, each sample was genotyped on the Illumina
HumanOmni1-Quad as an initial DNAQC and for in-house assess-
ment of gender and familial relations. During library preparation,
DNA quality and size distribution were confirmed with the
Bioanalyzer. After library preparation, the samples were run
through a short paired-end sequencing reaction for ensuring
that the GC bias and sequencing quality were within the normal
ranges. Sequencing was subsequently performed on the Illumina
HiSeq 2000, and each sample was run on a unique lane. Each
lane was quality controlled during and after the run for ensuring
that 80% of the bases achieved at least a base quality score of 30;
otherwise, the lane was put through for another sequence run.Read Assembly and Alignment
The Illumina proprietary sequence-data analysis module CASAVA
(Consensus Assessment of Sequence and Variation) v.1.8 was used
for read assembly and alignment. In brief, CASAVA performs
sequence read alignment with the Efficient Large-Scale Alignment
of Nucleotide Databases (ELAND) v.2e software, which processes
the short reads by constructing a hash table of the short reads
and scans the genome to identify matches before mapping to
the respective section in the reference genome with the highest
posterior probability. ELAND v.2e performs gapped alignment
that extends each candidate alignment to the full read length
and also employs multiseed alignment of consecutive sets of
16–32 bases separately to minimize artifactual mismatches. We
used NCBI build 37 of the reference genome, although we maskederican Journal of Human Genetics 92, 52–66, January 10, 2013 53
out the pseudoautosomal region on chromosome Y to avoid
duplicate alignments on chromosome X. We aligned female
samples to the same reference without chromosome Y to avoid
ambiguous alignments of highly similar regions present on both
chromosomes X and Y. All generated reads were subsequently
consolidated into a single BAM file per sample as per standard
specification.26
SNP and Indel Discovery
For variants such as SNPs and short indels, twomethods were used
for discovery: (1) a single-sample variant caller in CASAVA and (2)
the multisample variant-caller mpileup module in SAMtools
v.0.1.17. To reduce the likelihood of false discoveries due to the
choice of the variant caller, we only utilized the consensus set of
variants identified by both CASAVA and SAMtools (see Supple-
mental Methods at the SSMP website in theWeb Resources). Func-
tional annotation of the variants was carried out with ANNOVAR
(November 2011 release)27 with the ENSEMBL reference database.
For exonic SNPs, both SIFT28 and PolyPhen-229 were used for pre-
dicting the possible impact of the amino acid substitution. To
avoid conflicting inference, we only defined a nonsynonymous
SNP (nsSNP) as damaging if both SIFT yielded a score % 0.05
and PolyPhen-2 yielded a score R 2.
Deletion Discovery
Two paired-end approaches, BreakDancer v.1.130 and Variation-
Hunter v.0.3,31 were used for detecting large deletions in excess
of 50 bp. To avoid false discoveries, we only used reads with
a mapping quality score > 35 as inputs to both methods. Break-
Dancer identifies a region to carry deletions if all four of the
following conditions are satisfied: (1) the region achieves a Break-
Dancer confidence scoreR 25, (2) there are at least three distinct
reads supporting the presence of the deletion, (3) both paired-end
reads are mapped to the same chromosome, and (4) the deleted
region is not found in the centromere. Within each individual,
overlapping deletions are subsequently merged into a single
deletion. For the output fromVariationHunter, only deletions sup-
ported by at least three distinct reads and not present in the
centromere are retained. We report only the set of deletions that
were detected by both BreakDancer and VariationHunter and are
between 50 and 10 Mb in length. A deletion is defined as previ-
ously identified if at least 50% of the deletion overlaps with previ-
ously reported deletions in the Database of Genomic Variants
(DGV, November 2010 release) or the 1KGP.
LOF Variants
In silico annotation of LOF variants was performed with reference
to the ENSEMBL gene annotation release 66.32 This focused on
exonic variants classified as stop-gain or stop-loss mutations
because such variants have the potential to result in the gain or
loss of stop codons.33 Indels annotated as frameshift, stop-loss,
and stop-gain mutations were also classified as LOF variants. In
addition, we required the SNP or indel to be located in a protein-
coding gene with corresponding protein-coding transcription.
Assessing Population Structure
To verify the ethnic membership of the 100 SSMP samples, we per-
formed a principal-component analysis (PCA) between the 100
SSMP samples and the 268 samples from the SGVP7 with the pca
option in the EIGENSTRAT software.34 The PCA was performed
on a set of 111,776 SNPs, which we obtained by using every fifth54 The American Journal of Human Genetics 92, 52–66, January 10, 2SNP from the set of 558,882 SNPs present in both the SGVP
samples and the Illumina Omni1-Quad array.
Identifying Mutation Hotspots
In order to evaluate whether there are human genomic regions
that carry an uncharacteristically high density of SNPs, we divided
each autosomal chromosome into 1 Mb nonoverlapping bins and
counted the number of SNPs in each of the three following cate-
gories in each bin: (1) all SNPs, (2) nsSNPs, and (3) damaging
nsSNPs. We used the human-leukocyte-antigen (HLA) region in
the major histocompatibility complex (MHC) on chromosome 6
as a benchmark to identify mutation hotspots, defined as regions
that carry at least 50% of the density (of all SNPs) observed at the
densest window in the HLA. We did not identify hotspots of
nsSNPs but instead identified any regions containing a greater
density of damaging nsSNPs than the densest signal at the HLA
region. To avoid genomic regions carrying a higher density of
repeats, we excluded findings found within 1 Mb of the start
and end of the telomeres and centromeres.
Assessing Impact of Sequencing Coverage
For the 96 samples, we thinned the sequence reads on chromo-
some 20 from 303 to 53 coverage in decreasing step sizes of 53
by using the DownsampleSammodule in Picard v.1.5.5. Multisam-
ple variant calling was performed at each step size with SAMtools
mpileup, which allowed an assessment of the extent of identified
variants across the allele-frequency spectrum as sequencing depth
changed. In addition, we thinned the sequence reads across the
whole genome from 303 to 53 to assess the extent of the variants
that would be missed when sequencing at a depth similar to that
of the 1KGP.
Assessing Genomic Coverage of Genotyping
Microarrays
We quantified and calculated the pairwise LD between two SNP
markers by using the r2 metric and PLINK v.1.07, respectively.
We only considered SNPs located within a physical distance of
250 kb of each other. To calculate the genomic coverage of the
study population panel on each DNA SNP array, we first consid-
ered a reference set of SNP variants R that were unambiguously
determined and were assumed to be the complete set of SNPs in
the population. Let D denote the set of SNPs located on a given
SNP genotyping array. Note that D is not a complete subset of R
because the selected SNPs to be placed on the array might not
necessarily be polymorphic in the target population and, as
such, might not be found in R. For the given set of selected tag
SNPs D, some SNPs in R are either (1) contained in both D and R
(we denote this as set T) or (2) in LD with at least one SNP in D
according to a predefined LD threshold (we denote this as set L).
We thus proceeded to estimate the genomic coverage of a specific
DNA genotyping array on a specified population panel as (T þ L) /
R, where L changes depending on the specific r2 threshold applied
and both T and R remain constant for each population group and
array evaluated. The calculation of coverage for the exome geno-
typing arrays is similar to that of the genome-wide calculation
described earlier with the exception that, here, we restricted the
complete set of SNPs to be constrained to those located in the
exon regions rather than genome-wide. For SNP annotation,
we used the software ANNOVAR27 with annotations from the
ENSEMBL gene database, in which R SNPs annotated to be either
within an exon or exon splicing constitute the reference set of013
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Figure 1. PCA of Samples from the SSMP
and SGVP
PCA of the 100 samples from the SSMP
(black circles) and the 268 samples from
the SGVP, which includes 96 Chinese
(red), 89 Malays (green), and 83 Indians
(blue). A set of 111,776 SNPs present
on the Illumina Omni1-Quad array, as
well as in the SGVP, was used for this
analysis.complete polymorphisms in the exomes. These exonic SNPs can
be further divided into various classes according to their functions:
nonsynonymous, synonymous, splicing, frameshift, stop-gain,
and stop-loss mutations.Comparison of Reference Panels in Genotype
Imputation
We evaluated the performance of genotype imputation with 2,542
Singapore Malays who were genotyped on the Illumina Human-
Hap610Quad array as part of a genome-wide association study
on eye-related disorders and traits.35–38 We considered two impu-
tation reference panels, (1) phased haplotypes from the 96 Malays
in SSMP (see Supplemental Methods at the SSMP website for
details of the haplotype phasing) and (2) phased haplotypes
from 1,092 samples from 14 populations in phase 1 of the 1KGP
(this later panel constitutes a ‘‘cosmopolitan’’ panel for genotype
imputation). We adopted a two-step imputation strategy in which
we prephased the 2,542 target samples at the chromosomal level
by usingMaCH v.1.07 before genotype imputation with Minimac.
We removed SNPs with imputation quality scores < 0.8 from
further analyses of imputation accuracy, leaving us with 517,234
SNPs that were on the microarray and that thus possessed assayed
genotype calls for the 2,542 samples. At each SNP, we calculated
the square of the Pearson’s correlation coefficient (r2) between
the assayed genotype calls and the allele dosages from the imputa-
tion for all the samples with valid genotype calls. We binned each
SNP into 1 of 11 MAF bins and computed the proportion of SNPs
in each bin with r2 < 0.9.
A full description of our methods, along with additional figures
and tables, can be found in the Supplemental Methods at the
SSMP website.Results
Sequence-Data Assembly, Alignment, and QC
A total of 100 subjects, comprising 50 males and 50
females from the Singapore Population Health Study,The American Journal of Humanwere whole-genome sequenced with
the Illumina HiSeq 2000 with a target
coverage of 303, 100 bp paired-end
reads, and a target insert size of 300–
400 bp. Sequence-read assembly was
performed with the Illumina proprie-
tary CASAVA v.1.8 assembler, which
yielded around 145 billion paired-
end reads. These reads were mapped
to the NCBI build 37 referencegenome with the CASAVA GERALD module, which
performs ELAND v.2e mapping, and 88.5% of the reads
(1) passed Illumina QC filters, (2) were mapped with the
proper read-pair orientation, (3) had insert sizes within
the targeted size range, and (4) were not flagged as an
optical duplicate. Each sample was additionally genotyped
on the Illumina Omni1Quad array, and these genotypes
were used for preliminary sample QC, as well as for assess-
ing the accuracy of the genotype calling from the sequence
data. We performed a PCA of the 100 SSMP samples
together with the SGVP samples, and this identified one
SSMP sample (SSM048) that was distinctively of Asian
Indian origin (Figure 1); this sample was subsequently
excluded from downstream analysis. To minimize false
discoveries of structural variants, we also identified and
excluded samples with anomalous distribution of insert
sizes (SSM051, SSM054, and SSM060 [see Figure S1, avail-
able online]). This yielded a final set of 96 samples with
around 14.4 terabases (Tb) of unfiltered DNA bases for
further analyses. Details of the QC process can be found
in the Material and Methods and Supplemental Methods
online at the SSMP website.
For the 96 samples, an average of 97.11% (SD ¼
0.98%) of the reads were mapped to the reference
genome; in comparison, the low-coverage pilot of the
1KGP only reported 58.3% for Europeans (CEU [Utah
residents with ancestry from northern and western Eu-
rope from the CEPH collection]) and 78.5% for East
Asians (CHB [Han Chinese in Beijing, China] þ JPT
[Japanese in Tokyo, Japan]) (see Figure 2, Table 1 and
Table S1). Although we targeted a sequencing depth of
303, the 96 samples actually yielded a mean coverage
of 47.63 across all 96 samples and accessed an average
of 91.66% of the human genome. The depth of coverage
for each sample ranged from a minimum of 35.53 to
a maximum of 81.93.Genetics 92, 52–66, January 10, 2013 55
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Discovered in the SSMP Compared to
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Variants detected in the SSMP include
SNPs, small indels between the sizes of
50 and 50 bp, and large deletions
between the sizes of 50 bp and 1 Mb. Vari-
ants identified by the 1KGP were com-
pared with those in NCBI build 36 and
dbSNP129, and variants identified by the
SSMP were compared with those in
dbSNP132 and the July 2010 release of
the 1KGP.SNP Discovery and Annotation
We used CASAVA and SAMtools/BCFtools to call variants
from the reads of each individual sample and to call
variants from the pooled reads from multiple samples,
respectively. Overall, we identified more SNPs with the
single-sample calling strategy than with the multisample
approach (Table S2), although we report only variants
that were discovered by both approaches. To decide which
set of genotype calls we would use to construct the SSMP
resource, we assessed the degree of concordance between
the sequence calls by both CASAVA and SAMtools mpileup
and the set of genotypes from the Omni1Quad genotyping
by identifying a consensus set of SNPs on the basis of
genomic coordinates. Although both approaches yielded
remarkably high degrees of concordance in excess of
99.2%, calls made by CASAVAwith the use of the sequence
data were found to exhibit a higher degree of concordance
with the genotyping calls (Figure S2). The public resource
and downstream analyses were thus based on the genotype
calls made by CASAVA.
Of the 96 Malay samples, we discovered a total of
13,989,823 biallelic SNPs with a genome-wide transition-
to-transversion (Ti:Tv) ratio of 2.17 (Table 2). The Ti:Tv
ratio did not differ significantly between those SNPs
present in and those SNPs absent from dbSNP (2.18 versus
2.15, respectively), although the ratio was much higher (at
3.02) for SNPs in the exome than for the genome-wide
average. When assessed against dbSNP132, which includes
the variants reported in the pilot phase of the 1KGP, 42%
of the biallelic SNPs were absent (Table S3). We also
observed 43,327 triallelic and quadallelic SNPs, of which
26.4% were absent from dbSNP (Table S4). For the biallelic
SNPs, the largest proportion of the known SNPs (67.8%)
had a MAF > 5% (defined subsequently as common),56 The American Journal of Human Genetics 92, 52–66, January 10, 2013whereas 15.6% had a MAF between
1% and 5% (low frequency) and the
remaining 16.6% had a MAF < 1%
(rare). Unsurprisingly, the majority
of the SNPs absent from dbSNP
were rare (77.9%), and only a small
fraction of them (5.8%) were com-
mon. Within each sample, the
number of SNPs detected ranged
from 3,519,881 to 3,672,553 SNPsper sample (mean ¼ 3,596,151; SD ¼ 26,785 [Figure 3]).
The ratio of heterozygous to homozygous SNPs per sample
had an average of 1.36 (SD¼ 0.057) when calculated across
all 96 samples. This ratio was 3.43 higher in the set of SNPs
absent from dbSNP than in the set of previously identified
SNPs, consistent with previous reports suggesting that
SNPs absent from publically available databases are more
likely to be rare and present in heterozygotes.20,28
ANNOVAR27 was used for classifying SNPs into eight
categories according to functional annotation. Most of
the SNPs were intergenic (48.12%) or intronic (36.51%),
and the remaining 15%, including 119,283 exonic SNPs
(of which 58,610 were absent from dbSNP), fell into the
other six categories (Figure S3). Of the exonic SNPs, nsSNPs
accounted for the largest proportion (57.7%), whereas
39.8% were synonymous (Table S5). Across 96 samples,
we discovered 37,379 nsSNPs, 971 stop-gain SNPs, and
180 stop-loss SNPs that were absent from dbSNP. Overall,
nsSNPs and synonymous SNPs made up 0.50% and
0.35% of the detected SNPs, respectively; these percentages
are similar to the numbers reported by the 1KGP (0.41%
and 0.37%, respectively). For the nsSNPs, we found that
15,439 were consistently predicted to be damaging by
both SIFT and PolyPhen.
Mutation Hotspots
Deep whole-genome sequencing offers an unprecedented
opportunity for investigating whether there are human
genomic regions with an enrichment of mutations, partic-
ularly those that result in amino acid changes and that are
predicted to be deleterious.We considered nonoverlapping
windows of 1 Mb across the genome and counted the
number of SNPs in each window. We additionally counted
the number of nsSNPs, as well as SNPs predicted by both
Table 1. Summary of Sequence Reads and Variants Discovered in SSMP
Summary Statistic SSMP CHB þ JPT CEU YRI
Number of Samples 96 60 60 59
Total raw bases (Gb) 14,421 596 1,402 874
Total mapped bases (Gb) 13,991 468 817 596
Mean mapped depth 47.58 2.65 4.62 3.42
Number of SNPs (% nonoverlapping) 14,033,150 (42.4%) 6,273,441 (28%) 7,943,827 (33%) 10,938,130 (47%)
Mean variant SNP sites per individual 3,596,151 2,810,573 2,918,623 3,335,795
Number of indels (% nonoverlapping) 1,599,717 (60.3%) 666,639 (39%) 728,075 (39%) 941,567 (52%)
Number of SV deletions (% nonoverlapping) 34,113 (60%) 15,893 (60%)
The values reported in the table for populations CHB þ JPT, CEU, and YRI are taken from the 1KGP and are based on NCBI build 36 and dbSNP129, whereas the
values reported for SSMP are based on NCBI build 37 and dbSNP132. Nonoverlapping variants are those found only in the SSMP. The following abbreviations are
used: SSMP, Singapore Sequencing Malay Project; CHB, Han Chinese in Beijing, China; JPT, Japanese in Tokyo, Japan; CEU, Utah residents with ancestry from
northern and western Europe from the CEPH collection; YRI, Yoruba in Ibadan, Nigeria; and SV, structural variation.SIFT and PolyPhen to be damaging. Densities of these
different categories of SNPs were observed to vary signifi-
cantly throughout the genome (Figure 4). For example,
the HLA region on chromosome 6 exhibited the highest
SNP density in the genome (Figure 4A), as well as consider-
ably higher densities of nsSNPs (Figure 4B) and damaging
SNPs (Figure 4C) than the genome-wide averages.
Using the HLA region as a benchmark, we identified four
other genomic regions that possess at least 50% of the SNP
density observed at the densest window in the HLA region
(Table 3). This included a 1 Mb chromosome 4 window en-
compassing beta-defensin 131 (DEFB131), dopamine
receptor D5 (DRD5), and a member of the solute carrier
family (SLC2A9); a 4 Mb chromosome 8 window spanning
several genes, including six members of the defensin gene
family (DEFB1, DEFA1, DEFA3, DEFA4, DEFA5, and
DEFA6); a 2 Mb chromosome 16 window spanning
ataxin-2-binding protein 1 isoform 4 (A2BP1); and a 1
Mb window between 78 and 79 Mb on chromosome 16
(Figure S4). Compared with the densest signal at the HLA
region, the following five regions emerged with higher
densities of damaging nsSNPs (Table 4): (1) chr1: 228–
229 Mb (including a gene implicated in basal cell carci-
noma and endometriosis [RHOU]); (2) chr2: 179–180 Mb
(including the titin isoform gene [TTN] implicated in QT-
interval variation); (3) chr3: 195–196 Mb (spanning
a pancreatic cancer gene [TFRC]); (4) chr7: 100–101 Mb
(spanning a transferrin-receptor gene [TFR2] and a geneTable 2. Ti:Tv Ratio for SNPs Discovered in SSMP
Ti:Tv Ratio
Whole Genome Exome
Previously identified SNPs 2.178 3.125
Nonoverlapping SNPs 2.153 2.917
All 2.167 3.020
Nonoverlapping SNPs are those found only in the SSMP.
The Amimplicated in type 2 diabetes [ACHE]); and (5) chr16: 88–
89 Mb (carrying genes reported to be associated with
central corneal thickness [BANP and ZNF469]).
A relevant corollary to the above findings is whether
these regions similarly exhibit a higher density of SNPs
currently absent from dbSNP or whether these regions
carry previously reported SNPs. For example, even though
the SNP and damaging nsSNP densities were significantly
higher at the HLA region, the corresponding density of
SNPs absent from dbSNP was considerably lower and did
not feature in the top signals across the genome
(Figure S5). Of the four regions first identified without
any category restriction on the SNPs, three regions (except
chr16: 78–79 Mb) similarly carried significantly higher
densities of SNPs absent from dbSNP. All five regions iden-
tified with a high density of damaging nsSNPs were present
in the top signals with the highest density of damaging
nsSNPs absent from dbSNP (Table S6).
Indels and Large Deletions
A total of 1,599,717 indels with sizes between 50 bp
(deletions) and þ50 bp (insertions) were discovered from
the sequencing of the 96 Malay subjects; an average of
558,343 indels (SD ¼ 16,564) were detected in each indi-
vidual. We compared our discoveries against those of
both dbSNP132 and the reported findings from the pilot
phase of the 1KGP, given that dbSNP132 did not include
the indels from the 1KGP. As expected, a significant
proportion of the common indels had been previously
identified, whereas a higher proportion of the rare and
low-frequency indels were absent from dbSNP (Table 1,
Figure 5). Annotating the indels with ANNOVAR, we
observed that 47.0% of the indels were intergenic, 38.3%
were intronic, and about 0.1% (2,298) were in the exonic
regions classified as frameshift, nonframeshift, stop-loss,
or stop-gain. Of the 2,298 exonic indels, nonframeshift in-
dels constituted the largest proportion (58.3%) and were
followed by frameshift (37.4%), stop-gain (1.3%), and
stop-loss (0.3%) mutations.erican Journal of Human Genetics 92, 52–66, January 10, 2013 57
Figure 3. Number of Variants in Indi-
vidual Whole-Genome Sequencing
Illustration of the number of variants
detected in the individual whole-genome-
sequencing projects that have been per-
formed, along with the number of samples
and the corresponding sequence depth.
The number shown at the start of each
horizontal bar indicates the exact number
of variants discovered in the individual
sequencing or the average number of
variants discovered in multisample se-
quencing (for the Koreans and theMalays).
The error bars for the multisample se-
quencing of the Koreans and Malays
show the minimum and the maximum
number of variants detected across the
samples.Deletions between 50 and 10 Mb were identified with
VariationHunter31 and BreakDancer,30 two paired-end-
mapping approaches. Across all 96 samples, we found
34,113 deletions, of which 13,650 (40.0%) overlapped
with deletions reported either in the DGV (November
2010 release) or in the 1KGP. Unsurprisingly, a significant
proportion (53.0%) of the 20,463 nonoverlapping dele-
tions were seen in at most 1% of the 96 samples, whereas
5,798 were found with a frequency between 1% and 5%
and only 3,821 were common (frequency > 5%) (Table
1). With the use of similar QC criteria, our samples yielded
18,220 more deletions than the 1KGP despite the fact that
the pilot phase of 1KGP assayed almost twice as many
samples as we had. We believe this is attributed to the
significantly deeper coverage that the SSMP possesses
given that thinning the read depth from 303 to 53 for
four randomly chosen SSMP samples yielded only about
half of the deletions that would have been found with
303 coverage in these four samples (Figure S6). However,
for those deletions that were consistently identified with
both 53 and 303 coverage data, the sizes of the deletions
were remarkably similar (Figure S7).
LOF Variants
From the set of SNPs and indels annotated to be stop-loss
or stop-gain mutations or to result in frameshifts, we
identified in 2,505 genes 2,782 variants that were likely
to result in LOF. An average of 470 LOF variants were
seen in each sample, consistent with previous whole-
genome sequencing that reported between 200 and 800
LOF variants per healthy individual.28,39 Comparing
against the samples in the low-pass pilot phase of the
1KGP, we observed almost twice as many LOF variants
per individual (Table S7 and Figure S8). Comparing the
LOF variants that emerged from the SSMP with the58 The American Journal of Human Genetics 92, 52–66, January 10, 2013reported list of validated LOF vari-
ants, we observed that 95 of the
LOF variants in our samples were
also observed in the 1KGP and were
functionally validated, suggestingthat these mutations are genuine and not sequencing arti-
facts. (Table S8).
Variant Discovery versus Coverage
We expected the high-coverage sequencing to uncover
more variants than low-pass sequencing. To investigate
this formally, we varied the read depth from 53 to 303
in each of the 96 samples on chromosome 20 and reper-
formed the multisample variant calling with SAMtools to
evaluate the number of SNPs and indels detected (Table
S9). Although it is clear that a monotonically increasing
relationship exists between sequencing depth and the
number of variants detected (Figure S9), there appears to
be, at best, a modest increase in variant discovery beyond
203 coverage. Examining SNP discovery by the allele-
frequency spectrum, we observed that sequencing at
a deep coverage primarily benefitted the discovery of vari-
ants at lower MAFs, particularly those at 1% or less
(Figure S10). We additionally thinned the whole-genome
sequence data for all 96 samples to 53 and reperformed
the variant calling to investigate the consequence of
sequencing at a coverage similar to that of the 1KGP pilot
phase. Out of 14,033,150 SNPs that were observed in
the sequencing at 303 coverage, we recovered only
11,336,667 (80.8%) SNPs. Of those that were not present
in the low-pass sequencing, the majority were low-
frequency and rare variants (97.5%) (see Figure 6).
Validation Sequencing
In order to assess the reliability of the discovered variants,
we randomly selected 11 samples and resequenced chro-
mosome 20 by using a NimbleGen sequence-capture
approach (SeqCap EZ Choice XL library) to cover all
63,025,520 bases. Samples were sequenced on the Illumina
HiSeq1000, and the reads were mapped to Hg19 with
AB
C
Figure 4. Density of SNPs in the SSMP
Density of SNPs discovered in the SSMP.
Each chromosome is divided into
nonoverlapping windows of 1 Mb and
the number of SNPs in each of the three
categories: all SNPs (A), nsSNPs (B), and
damaging nsSNPs (C). Horizontal dashed
lines correspond to the thresholds used
for defining the regions of interest where
the SNP densities are at least 50% of those
observed at the HLA region on chromo-
some 6.ELAND v.2e. SNPs and indels were subsequently called
with a different caller with the Genome Analysis Toolkit
(GATK, see Supplemental Methods at the SSMP website).
An average per-sample coverage of 45.113 was attained
(Table S10). Out of the 167,277 SNPs identified by both
CASAVA and SAMtools in the main experiment for only
the 11 samples on chromosome 20 (defined as the
consensus set), 145,670 (87.08%) were consistently
observed in the validation sequencing (Table S11 and
Figure S11). Although 12,957 SNPs were found by the vali-
dation sequencing only, these tended to correspond to
SNPs for which the GATK quality scores were significantly
lower than those present in both the consensus set and the
validation sequencing (Table S12). The concordanceTable 3. Summary Information of Genomic Regions Possessing at Least 50% of the SNP Dens
Chromosome 6
Chromosome
Start
(Mb)
End
(Mb)
Density
(Number of
SNPs per Mb) Genes
4 9 10 9,961 DEFB131, DRD5, SLC2A9, and USP17
6 29 30 11,162 GABBR1, HCG4P7, HCG4P8, HLA-F, MAS1L,
OR14J1, OR2B3, OR2H1, OR2H2, OR2J2, OR2
6 31 33 11,162
12,094
ABHD16A, AGER, AGPAT1, AIF1, APOM, ATF
BAG6, BRD2, C6orf15, C6orf25, C6orf47, C6o
CYP21A2, DDAH2, DDX39B, DOM3Z, EGFL8
HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB,
HLA-DQB2, HLA-DRA, HLA-DRB1, HLA-DRB
LTA, LTB, LY6G5B, LY6G5C, LY6G6D, MCCD
NEU1, NFKBIL1, PBX2, POU5F1, PPT2, PRRC
PSORS1C2, RDBP, RNF5, SAPCD1, SKIV2L, SL
TNXB, VARS, and ZBTB12
8 3 7 14,176
11,418
11,801
10,027
AGPAT5, ANGPT2, CSMD1, DEFA1, DEFA1B,
MCPH1, and XKR5
16 6 8 9,666
9,479
RBFOX1
16 78 79 10,027 CLEC3A, WWOX, and VAT1L
The American Journal of Humanbetween the GATK genotype calls
and the Omni1Quad calls was
observed to be lower than those re-
ported in the consensus set, parti-
cularly for the common SNPs for
which the concordance was only
99.5% (compared to 99.9% from theCASAVA calls in the consensus set [Table S13]). For indels,
16,761 out of 22,876 (73.27%) in the consensus set were
present in the validation sequencing. Similarly, we
observed that the set of 5,365 indels that were solely
discovered by the validation sequencing exhibited lower
GATK quality scores than did those present in the
consensus set (Table S12).
Coverage Assessment of Next-Generation Genotyping
Arrays
The SSMP resource provides a unique opportunity for
investigating the genomic coverage of next-generation
genotyping microarrays designed with information from
the IKGP pilot phase, such as the two exome arrays thatity Observed at the HLA Region on
MOG, OR10C1, OR11A1, OR12D2, OR12D3,
J3, OR2W1, OR5V1, UBD, and ZFP57
6B, ATP6V1G2, ATP6V1G2-DDX39B,
rf48, CCHCR1, CDSN, CFB, CLIC1, CSNK2B,
, EHMT2, FKBPL, GPANK1, HLA-B, HLA-C,
HLA-DQA1, HLA-DQA2, HLA-DQB1,
5, HSPA1A, HSPA1B, HSPA1L, LSM2, LST1,
1, MICA, MICB, MSH5, MUC22, NCR3,
2A, PRRT1, PSG1, PSMB8, PSMB9, PSORS1C1,
C44A4, STK19, TAP1, TAP2, TCF19, TNF,
DEFA3, DEFA4, DEFA5, DEFA6, DEFB1,
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Table 4. Summary Information of Genomic Regions Possessing Higher Densities of Damaging Nonsynonymous SNPs than the HLA Region
on Chromosome 6
Chromosome
Start
(Mb)
End
(Mb)
Density
(Number of
SNPs per Mb) Genes
1 228 229 93 ARF1, BUTR1, C1orf35, GJC2, GUK1, HIST3H2A, HIST3H2BA, HIST3H2BB,
HIST3H3, IBA57, MRPL55, OBSCN, PRSS38, RHOU, RNF187, TRIM11,
TRIM17, WNT3A, and WNT9A
2 179 180 193 CCDC141, DFNB59, FKBP7, OSBPL6, PLEKHA3, PRKRA, SESTD1, and TTN
3 195 196 327 ACAP2, APOD, MUC20, MUC4, PCYT1A, PPP1R2, TFRC, TNK2, and ZDHHC19
6 31 33 77; 84 Same gene list as in Table 2
7 100 101 163 ACHE, ACTL6B, AGFG2, AP1S1, C7orf47, C7orf51, C7orf52, C7orf61, CLDN15,
DGAT2L7, EPHB4, EPO, FBXO24, FIS1, GIGYF1, GNB2, LRCH4, MEPCE, MOGAT3,
MOSPD3, MUC12, MUC17, MUC3A, PCOLCE, PLOD3, POP7, RABL5, SAP25,
SERPINE1, SLC12A9, SRRT, TFR2, TRIM56, TRIP6, TSC22D4, UFSP1, VGF, ZAN,
ZCWPW1, and ZNHIT1
16 88 89 95 APRT, BANP, CBFA2T3, CDT1, CTU2, CYBA, GALNS, IL17C, MVD, PABPN1L,
PIEZO1, RNF166, SNAI3, TRAPPC2L, ZC3H18, ZFPM1, and ZNF469focus on exonic content. Unsurprisingly, our findings indi-
cate that genomic coverage of the populations in the 1KGP
pilot phase tends to be higher for denser arrays that assay
more SNPs (Figure 7), and the coverage of low-frequency
SNPs was considerably lower than that of common SNPs,
except in the cases of the Illumina Omni2.5 and
Omni5.0 arrays.
For the common SNPs that we reported in SSMP, it was
observed that arrays designed specifically with East Asian
content (Affy AxiomASI and AxiomCHB, Illumina Zhong-
Hua), especially the Illumina ZhongHua, performed better
against other standard-content arrays that assayed similar
number of variants (Figure 7A). The coverage of all the
arrays for low-frequency and common SNPs identified in
the SSMP was considerably lower, even for the Omni2.560 The American Journal of Human Genetics 92, 52–66, January 10, 2and Omni5.0, which yielded at least 80% coverage with
a tagging threshold of r2 R 0.8 in 1KGP Europeans (CEU)
and East Asians (CHB þ JPT) (Figure 7B). Because coverage
assessment included the low-frequency SNPs, which are
not as easily tagged and are more likely to be population
specific, the poorer coverage for the Malays and Africans
was most likely the consequence of ascertainment biases
that prioritized SNPs present in Europeans and East Asians.
When comparing Omni2.5 with Omni5, we observed that
Omni5 actually yielded a perceptible improvement over
Omni2.5 in the coverage of low-frequency and common
variants in Europeans (CEU). This is in line with the design
of Omni5, which includes additional rare and low-
frequency content identified in the CEU population in
the pilot phase of the 1KGP.No.
No.
Figure 5. Size Distribution of Indels by
Population Frequency
Indels discovered in the SSMP are distrib-
uted by size and categorized into three
MAF bins: rare (%1%), low frequency
(1%–5%), and common (R5%). Previously
identified indels refer to those that are
present in dbSNP132 or in the July 2010
release of the IKGP (lower panel), whereas
nonoverlapping indels are defined as those
present in only the SSMP and not in either
dbSNP132 or the 1KGP (upper panel). The
lines shown in the upper panel indicate
the proportion of nonoverlapping indels
identified by the SSMP (orange line) and
the 1KGP (green).
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Figure 6. Number of SNPs Detectable by
Sequencing at Different Depths
Pictorial representation of the number of
SNPs detected by sequencing at 303 or
53 coverage. The blue bars represent the
number of SNPs found by both 53 and
303 sequencing, and the red bars repre-
sent those that were only detected by
sequencing at 303.Affymetrix and Illumina have introduced two exome
arrays that were designed to consider the functional exonic
SNP content from 16 major exome-sequencing projects,
including the pilot phase of the 1KGP. The primary
content of the Affy Axiom Exome carries 347,364 SNPs,
whereas the Illumina HumanExome BeadChip contains
241,326 SNPs. Our coverage calculations suggested that
the Affy exome array achieved almost 20% higher coverage
than the Illumina exome array in all four populations,
although, as expected, the coverage of the YRI (Yoruba in
Ibadan, Nigeria) samples was the lowest among all four
populations at around 40% for Illumina and 58% for Affy-
metrix at an r2 threshold of 0.8 (Figure 8). The rest of the
non-African populations achieved around 45% and 62%
coverage for Illumina and Affymetrix, respectively, and
there were no significant differences between the SSMP
and the other non-African populations. However, the
coverage of exonic variants in the SSMP decreased dramat-
ically when the evaluation of coverage was extended to
include low-frequency variants to the extent that the
SSMP actually exhibited a lower coverage than YRI.
Although there was no discernible difference in coverage
for the 1KGP populations upon the inclusion of the low-
frequency variants, there was almost a 10% drop in the
coverage of the SSMP variants; this most likely stems
from the poor coverage of the low-frequency content.
Comparison of Reference Panels in Genotype
Imputation
The sequencing of 96 Southeast Asian Malays allows the
evaluation of imputation strategies that have been
proposed for fine-mapping functional polymorphisms
with sequence-level data. For example, how should one
perform genotype imputation for a population (such as-
the Malays) that has not been included in the 1KGP?
There are two possible strategies here: (1) to use a
‘‘cosmopolitan reference panel,’’ defined as a haplotypeThe American Journal of Humanpanel constructed by the aggrega-
tion of samples from different popu-
lations that are available in databases
such as the 1KGP or (2) to use a pop-
ulation-specific panel obtained by
either targeted or whole-genome
sequencing of a smaller number of
samples from the same popula-
tion as the intended samples for
imputation.In order to address this, we considered 2,542 Singapore
Malays who were genotyped on the Illumina Human-
Hap610Quad as part of a study of eye traits and diseases.
These samples were imputed twice because we used two
different reference panels constructed from (1) the 96
Malay samples in the SSMP and (2) the 1,092 samples
across 14 populations in phase 1 of the 1KGP (cosmopol-
itan panel). We subsequently calculated the correlation r2
between the allele dosages from the imputation with the
actual genotype calls for 517,234 SNPs found on themicro-
array and considered the fraction of SNPs with r2 < 0.9 in
each of 11 MAF bins (Figure 9). We observed that for rare
and low-frequency SNPs (MAF < 5%), the use of the
much larger cosmopolitan panel yielded more accurate
imputation than did the use of the population-specific
panel, which is not surprising because a substantial
number (e.g., n > 400) of individuals need to be whole-
genome sequenced for rarer SNPs to surface in the first
place.9,10 For common SNPs (MAF > 5%), the Malay rese-
quencing panel achieved more accurate imputation than
did the cosmopolitan panel.
Discussion
The Singapore Sequencing Malay Project aims to provide
an unbiased characterization of the genomic architecture
of the Malays in Southeast Asia through whole-genome
sequencing of 100 individuals. We opted to sequence at
a target coverage of 303 rather than to adopt the 1KGP
strategy of performing low-pass sequencing because we
believe that deep coverage is vital for uncovering variants
that are present at lower frequencies in the population.
Given that the Malays belong to the Austronesian group,
which is underrepresented in population-genetics studies,
we believe that the SSMP will yield valuable insights into
how this population differs from other major groups in
the world. The SSMP data are publicly available forGenetics 92, 52–66, January 10, 2013 61
Figure 7. Genomic Coverage of Genotyping Arrays
Coverage of SNP variation for Southeast Asian Singapore Malays (SSM), Europeans (CEU), East Asians (CHB þ JPT), and Africans (YRI)
from the 1KGP on various commercially available genome-wide genotyping arrays.
(A) SNPs of common frequency (R5% in each population) were assessed.
(B) SNPs of low and common frequency (R1% in each population) were assessed.researchers in the VCF that is identical to that of the
1KGP.
Our findings reiterate that low-pass sequencing tends to
miss low-frequency and rare variants, consistent with
several reports on targeted gene sequencing that investi-
gated the impact of sequence depth on variant
discovery.15,41 Because the majority of genuine LOF vari-
ants tend to be of low frequency in the population,28,40
sequencing deeply across multiple samples is likely to be
necessary for discovering more of these variants. Although
the low-passing sequencing in the 1KGP pilot phase has
delivered an unsurpassed resource that documents the
genomic diversity of several populations, the high-
coverage in the SSMP meant that we could interrogate
the genome in an unbiased fashion for regions that possess
a higher SNP density, especially those regions harboring
nsSNPs that are predicted to be potentially damaging.
Although it is premature to give any biological significance
to these regions, the fact that these genomic regions carry
an uncharacteristically high density of damaging nsSNPs
warrants careful investigation, especially because most of
these nsSNPs are absent from dbSNP.
One interesting question that arose during the design of
the SSMP was whether it would be better to sequence at
a lower depth but to include more samples rather than to62 The American Journal of Human Genetics 92, 52–66, January 10, 2sequence deeply but to compromise on the sample size.
To investigate this, we randomly chose 20 samples that
were sequenced at 303 and compared the number of vari-
ants observed to the number present from 96 samples after
we thinned the sequence coverage to 53. Although the
two scenarios required approximately the same amount
of sequencing, the first scenario yielded 9,051,538 vari-
ants, whereas the second scenario yielded 11,442,159 vari-
ants. This suggests that low-pass sequencing of more
samples uncovers more variants than does deep se-
quencing with a smaller sample size, although most of
the additional variants found were rare or of low frequency
(Table S9). The number of common variants detected by
both scenarios was similar (5.80 million SNPs for 96
samples compared to 5.75 million SNPs for 20 samples).
Although this seems to suggest that low-pass sequencing
of more samples is a better strategy, we emphasize,
however, that this depends on which of the following
two scenarios one aims to accomplish: (1) to discover as
many variants as possible given a fixed amount of
sequencing or (2) to detect as many variants genuinely
present within the sequenced individuals as possible. In
the former scenario, sequencing as many samples as
possible clearly yields more variants as the number of
private mutations increases with the number of013
Figure 8. Genomic Coverage of Exome
Arrays
The percentage of variation covered by the
two currently commercially available
exome-focused genotyping arrays for the
different 1KGP population groups: South-
east Asia Singapore Malays (SSM), Euro-
peans (CEU), East Asians (CHB þ JPT),
and Africans (YRI). Assessment of the
coverage of common exonic variants by
the Illumina HumanExome Beadchip (A)
and the Affymetrix Axiom Exome Array
(B) are shown. Additionally, low-frequency
exonic SNPs are included in the coverage
assessment of the Illumina HumanExome
Beadchip (C) and Affymetrix Axiom
Exome Array (D).individuals sequenced, but our study (see Figure 6) has re-
vealed that this comes at the expense of imperfect coverage
for each individual sample. In the latter scenario, deeper
sequencing yields a better ability to characterize the vari-
ants that are present within each sample, although this
misses rare or low-frequency variants that are simply not
carried by the sequenced individuals. In our assessment
of variant discovery versus sequencing coverage, we have
already established that the majority of variants that areFigure 9. Comparison of Reference Panels in Genotype Imputa-
tion
Evaluation of the performance of genotype imputation of 2,542
Singapore Malays who were genotyped on the Illumina610 array
against the two reference panels constructed from (1) 96 Malays
from the SSMP and (2) 1,092 samples from 14 populations in
phase 1 of the 1KGP. The correlation r2 between the allele dosages
and the actual genotype calls was calculated for each SNP on the
microarray. The vertical bars represent the percentage of SNPs in
each MAF bin where r2 is less than 0.9. The figure at the top of
each frequency bin represents the number of SNPs with a MAF
(calculated from 2,542 Malay samples) that falls within the
frequency spectrum of the bin. The vertical axis is represented in
logarithmic scale for ease of interpretation.
The American Journal of Humanmissed from low-pass sequencing are
rare and of low frequency. Clearly,
there are merits in both approaches,
and what is appropriate depends on
the underlying research hypothesis.
In the SSMP, we sought a compromisein which our deep-sequencing coverage would allow us to
provide an unbiased characterization of variants in the
Malay population with a MAF of at least 0.5%, although
this does assume that such variants are polymorphic in
the 96 Malay individuals.
Our results indicate that the use of a population-specific
reference panel during genotype imputation can lead to
more accurate inference of genotypes at unobserved
common SNPs than the use of a cosmopolitan reference
panel for a population such as the Malays, who are not
part of the International HapMap Project or the 1KGP.
When assessed for SNPs for which the derived allele
frequencies are less than 5%, our current sample size of
96 whole-genome sequenced Malay individuals was out-
performed by the 1KGP, which had 1,092 samples and
delivered more accurate genotype imputation. The most
likely reason for this observation is that a reference panel
containing more individuals has a higher chance of
carrying low-frequency and rare variants. For example,
for an allele that is found at 1% in a number of popula-
tions, a reference panel of 1,000 samples means that we
expect 20 copies of the allele to be present, and this figure
reduces to only two copies in a panel of 100 samples. This
discovery is important when one attempts to localize
the functional polymorphisms driving genotype-pheno-
type correlations observed in GWASs. A previous report
by Jallow and colleagues noted a strong association
between variants in the vicinity of the HBB locus on chro-
mosome 11 and severe onset of malaria in a collection of
Gambian samples.42 The authors successfully identified
causal variant rs334 by imputing against a population-
specific panel built from targeted resequencing of 60
Gambian samples across the HBB locus. This illustrates
the potential of the SSMP resource in furthering biologicalGenetics 92, 52–66, January 10, 2013 63
discoveries: providing a high-fidelity population-specific
reference panel for imputation-based fine mapping of
functional variants. Such approaches are currently being
built on and extended to large-scale GWASs involving indi-
viduals of Southeast Asian descent so that more of the
allelic spectrum accounting for individual disease severity
can be defined.43–46
To date, the SSMP has provided one of the deepest
whole-genome-sequencing resources across multiple
subjects in a single population. This is a timely comple-
ment to the 1KGP just as it releases whole-genome-
sequencing data of more populations from different parts
of the world. That this is performed in a population from
Southeast Asia is significant given that the 1KGP currently
includes only one population from this region (Viet-
namese Kinh) and none from the Austronesian groups.
We envisage that the SSMP database will be a useful
benchmark for population-level deep whole-genome
sequencing, and we expect that high coverage will enable
methodological and technological assessments of current
strategies in sequence-data analysis.
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download.html#_Toc214817256
Picard, http://picard.sourceforge.net/
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VariationHunter, http://compbio.cs.sfu.ca/software-variation-hunterAccession Numbers
The Database of Genomic Variants accession number for the struc-
tural variants reported in this paper is estd201.References
1. Frazer, K.A., Ballinger, D.G., Cox, D.R., Hinds, D.A., Stuve, L.L.,
Gibbs, R.A., Belmont, J.W., Boudreau, A., Hardenbol, P., Leal,
S.M., et al.; International HapMap Consortium. (2007). A
second generation human haplotype map of over 3.1 million
SNPs. Nature 449, 851–861.
2. International HapMap Consortium. (2003). The International
HapMap Project. Nature 426, 789–796.
3. Altshuler, D.M., Gibbs, R.A., Peltonen, L., Altshuler, D.M.,
Gibbs, R.A., Peltonen, L., Dermitzakis, E., Schaffner, S.F., Yu,
F., Peltonen, L., et al.; International HapMap 3 Consortium.
(2010). Integrating common and rare genetic variation in
diverse human populations. Nature 467, 52–58.
4. Hinds, D.A., Stuve, L.L., Nilsen, G.B., Halperin, E., Eskin, E.,
Ballinger, D.G., Frazer, K.A., and Cox, D.R. (2005). Whole-
genome patterns of common DNA variation in three human
populations. Science 307, 1072–1079.
5. Easton, D.F., Pooley, K.A., Dunning, A.M., Pharoah, P.D.,
Thompson, D., Ballinger, D.G., Struewing, J.P., Morrison, J.,
Field, H., Luben, R., et al.; SEARCH collaborators; kConFab;
AOCS Management Group. (2007). Genome-wide association
study identifies novel breast cancer susceptibility loci. Nature
447, 1087–1093.
6. Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D.,
Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007). A
genome-wide association study identifies novel risk loci for
type 2 diabetes. Nature 445, 881–885.
7. Teo, Y.Y., Sim, X., Ong, R.T., Tan, A.K., Chen, J., Tantoso, E.,
Small, K.S., Ku, C.S., Lee, E.J., Seielstad, M., and Chia, K.S.
(2009). Singapore Genome Variation Project: a haplotype
map of three Southeast Asian populations. Genome Res. 19,
2154–2162.
8. Xu, H., Poh, W.T., Sim, X., Ong, R.T., Suo, C., Tay, W.T., Khor,
C.C., Seielstad, M., Liu, J., Aung, T., et al. (2011). SgD-CNV,
a database for common and rare copy number variants in
three Asian populations. Hum. Mutat. 32, 1341–1349.
9. Rafnar, T., Gudbjartsson, D.F., Sulem, P., Jonasdottir, A.,
Sigurdsson, A., Jonasdottir, A., Besenbacher, S., Lundin, P., Sta-
cey, S.N., Gudmundsson, J., et al. (2011). Mutations in BRIP1
confer high risk of ovarian cancer. Nat. Genet. 43, 1104–1107.
10. Holm, H., Gudbjartsson, D.F., Sulem, P., Masson, G., Helgadot-
tir, H.T., Zanon, C., Magnusson, O.T., Helgason, A., Saemunds-
dottir, J., Gylfason, A., et al. (2011). A rare variant in MYH6 is
associated with high risk of sick sinus syndrome. Nat. Genet.
43, 316–320.013
11. Sulem, P., Gudbjartsson, D.F., Walters, G.B., Helgadottir, H.T.,
Helgason, A., Gudjonsson, S.A., Zanon, C., Besenbacher, S.,
Bjornsdottir, G., Magnusson, O.T., et al. (2011). Identification
of low-frequency variants associated with gout and serum uric
acid levels. Nat. Genet. 43, 1127–1130.
12. Bhangale, T.R., Rieder, M.J., and Nickerson, D.A. (2008).
Estimating coverage and power for genetic association
studies using near-complete variation data. Nat. Genet. 40,
841–843.
13. Wall, J.D., Cox, M.P., Mendez, F.L., Woerner, A., Severson, T.,
and Hammer, M.F. (2008). A novel DNA sequence database
for analyzing human demographic history. Genome Res. 18,
1354–1361.
14. Ng, S.B., Turner, E.H., Robertson, P.D., Flygare, S.D., Bigham,
A.W., Lee, C., Shaffer, T., Wong, M., Bhattacharjee, A., Eichler,
E.E., et al. (2009). Targeted capture and massively parallel
sequencing of 12 human exomes. Nature 461, 272–276.
15. Bentley, D.R., Balasubramanian, S., Swerdlow, H.P., Smith,
G.P., Milton, J., Brown, C.G., Hall, K.P., Evers, D.J., Barnes,
C.L., Bignell, H.R., et al. (2008). Accurate whole human
genome sequencing using reversible terminator chemistry.
Nature 456, 53–59.
16. Kim, J.I., Ju, Y.S., Park, H., Kim, S., Lee, S., Yi, J.H., Mudge, J.,
Miller, N.A., Hong, D., Bell, C.J., et al. (2009). A highly anno-
tated whole-genome sequence of a Korean individual. Nature
460, 1011–1015.
17. Schuster, S.C., Miller, W., Ratan, A., Tomsho, L.P., Giardine, B.,
Kasson, L.R., Harris, R.S., Petersen, D.C., Zhao, F., Qi, J., et al.
(2010). Complete Khoisan and Bantu genomes from southern
Africa. Nature 463, 943–947.
18. Wang, J., Wang, W., Li, R., Li, Y., Tian, G., Goodman, L., Fan,
W., Zhang, J., Li, J., Zhang, J., et al. (2008). The diploid genome
sequence of an Asian individual. Nature 456, 60–65.
19. Tong, P., Prendergast, J.G., Lohan, A.J., Farrington, S.M.,
Cronin, S., Friel, N., Bradley, D.G., Hardiman, O., Evans, A.,
Wilson, J.F., and Loftus, B. (2010). Sequencing and analysis
of an Irish human genome. Genome Biol. 11, R91.
20. Wheeler, D.A., Srinivasan, M., Egholm, M., Shen, Y., Chen, L.,
McGuire, A., He,W., Chen, Y.J., Makhijani, V., Roth, G.T., et al.
(2008). The complete genome of an individual by massively
parallel DNA sequencing. Nature 452, 872–876.
21. Durbin, R.M., Abecasis, G.R., Altshuler, D.L., Auton, A.,
Brooks, L.D., Gibbs, R.A., Hurles, M.E., and McVean, G.A.;
1000 Genomes Project Consortium. (2010). A map of human
genome variation from population-scale sequencing. Nature
467, 1061–1073.
22. Green, P. (2007). 2x genomes—does depth matter? Genome
Res. 17, 1547–1549.
23. Abdulla, M.A., Ahmed, I., Assawamakin, A., Bhak, J., Brahma-
chari, S.K., Calacal, G.C., Chaurasia, A., Chen, C.H., Chen, J.,
Chen, Y.T., et al.; HUGO Pan-Asian SNP Consortium; Indian
Genome Variation Consortium. (2009). Mapping human
genetic diversity in Asia. Science 326, 1541–1545.
24. Hatin, W.I., Nur-Shafawati, A.R., Zahri, M.K., Xu, S., Jin, L.,
Tan, S.G., Rizman-Idid, M., and Zilfalil, B.A.; HUGO Pan-Asian
SNP Consortium. (2011). Population genetic structure of
peninsular Malaysia Malay sub-ethnic groups. PLoS ONE 6,
e18312.
25. Edinur, H.A., Zafarina, Z., Spı´nola, H., Nurhaslindawaty, A.R.,
Panneerchelvam, S., and Norazmi, M.N. (2009). HLA poly-
morphism in six Malay subethnic groups in Malaysia. Hum.
Immunol. 70, 518–526.The Am26. Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer,
N., Marth, G., Abecasis, G., and Durbin, R.; 1000 Genome
Project Data Processing Subgroup. (2009). The Sequence
Alignment/Map format and SAMtools. Bioinformatics 25,
2078–2079.
27. Wang, K., Li, M., and Hakonarson, H. (2010). ANNOVAR:
functional annotation of genetic variants from high-
throughput sequencing data. Nucleic Acids Res. 38, e164.
28. Ng, P.C., Levy, S., Huang, J., Stockwell, T.B.,Walenz, B.P., Li, K.,
Axelrod, N., Busam, D.A., Strausberg, R.L., and Venter, J.C.
(2008). Genetic variation in an individual human exome.
PLoS Genet. 4, e1000160.
29. Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gera-
simova, A., Bork, P., Kondrashov, A.S., and Sunyaev, S.R.
(2010). A method and server for predicting damaging
missense mutations. Nat. Methods 7, 248–249.
30. Chen, K., Wallis, J.W., McLellan, M.D., Larson, D.E., Kalicki,
J.M., Pohl, C.S., McGrath, S.D., Wendl, M.C., Zhang, Q.,
Locke, D.P., et al. (2009). BreakDancer: an algorithm for
high-resolution mapping of genomic structural variation.
Nat. Methods 6, 677–681.
31. Hormozdiari, F., Hajirasouliha, I., Dao, P., Hach, F., Yorukoglu,
D., Alkan, C., Eichler, E.E., and Sahinalp, S.C. (2010).
Next-generation VariationHunter: combinatorial algorithms
for transposon insertion discovery. Bioinformatics 26, i350–
i357.
32. Flicek, P., Amode, M.R., Barrell, D., Beal, K., Brent, S., Chen, Y.,
Clapham, P., Coates, G., Fairley, S., Fitzgerald, S., et al. (2011).
Ensembl 2011. Nucleic Acids Res. 39(Database issue), D800–
D806.
33. Stenson, P.D., Ball, E., Howells, K., Phillips, A., Mort, M., and
Cooper, D.N. (2008). Human Gene Mutation Database:
towards a comprehensive central mutation database. J. Med.
Genet. 45, 124–126.
34. Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E.,
Shadick, N.A., and Reich, D. (2006). Principal components
analysis corrects for stratification in genome-wide association
studies. Nat. Genet. 38, 904–909.
35. Vithana, E.N., Khor, C.C., Qiao, C., Nongpiur, M.E., George,
R., Chen, L.J., Do, T., Abu-Amero, K., Huang, C.K., Low, S.,
et al. (2012). Genome-wide association analyses identify three
new susceptibility loci for primary angle closure glaucoma.
Nat. Genet. 44, 1142–1146.
36. Fan, Q., Barathi, V.A., Cheng, C.Y., Zhou, X., Meguro, A., Na-
kata, I., Khor, C.C., Goh, L.K., Li, Y.J., Lim, W., et al. (2012).
Genetic variants on chromosome 1q41 influence ocular axial
length and high myopia. PLoS Genet. 8, e1002753.
37. Han, S., Chen, P., Fan, Q., Khor, C.C., Sim, X., Tay, W.T., Ong,
R.T., Suo, C., Goh, L.K., Lavanya, R., et al. (2011). Association
of variants in FRAP1 and PDGFRA with corneal curvature in
Asian populations from Singapore. Hum. Mol. Genet. 20,
3693–3698.
38. Khor, C.C., Ramdas, W.D., Vithana, E.N., Cornes, B.K., Sim,
X., Tay, W.T., Saw, S.M., Zheng, Y., Lavanya, R., Wu, R., et al.
(2011). Genome-wide association studies in Asians confirm
the involvement of ATOH7 and TGFBR3, and further identify
CARD10 as a novel locus influencing optic disc area. Hum.
Mol. Genet. 20, 1864–1872.
39. Pelak, K., Shianna, K.V., Ge, D., Maia, J.M., Zhu, M., Smith,
J.P., Cirulli, E.T., Fellay, J., Dickson, S.P., Gumbs, C.E., et al.
(2010). The characterization of twenty sequenced human
genomes. PLoS Genet. 6, 6.erican Journal of Human Genetics 92, 52–66, January 10, 2013 65
40. MacArthur, D.G., Balasubramanian, S., Frankish, A., Huang,
N., Morris, J., Walter, K., Jostins, L., Habegger, L., Pickrell,
J.K., Montgomery, S.B., et al.; 1000 Genomes Project
Consortium. (2012). A systematic survey of loss-of-function
variants in human protein-coding genes. Science 335,
823–828.
41. Ju, Y.S., Yoo, Y.J., Kim, J.-I., and Seo, J.-S. (2010). The first Irish
genome and ways of improving sequence accuracy. Genome
Biol. 11, 132.
42. Jallow, M., Teo, Y.Y., Small, K.S., Rockett, K.A., Deloukas, P.,
Clark, T.G., Kivinen, K., Bojang, K.A., Conway, D.J., Pinder,
M., et al.; Wellcome Trust Case Control Consortium; Malaria
Genomic Epidemiology Network. (2009). Genome-wide and
fine-resolution association analysis of malaria in West Africa.
Nat. Genet. 41, 657–665.
43. Cho, Y.S., Chen, C.H., Hu, C., Long, J., Ong, R.T., Sim, X.,
Takeuchi, F., Wu, Y., Go, M.J., Yamauchi, T., et al.; DIAGRAM
Consortium; MuTHER Consortium. (2012). Meta-analysis of66 The American Journal of Human Genetics 92, 52–66, January 10, 2genome-wide association studies identifies eight new loci for
type 2 diabetes in east Asians. Nat. Genet. 44, 67–72.
44. Okada, Y., Sim, X., Go, M.J., Wu, J.Y., Gu, D., Takeuchi, F.,
Takahashi, A., Maeda, S., Tsunoda, T., Chen, P., et al.; Kidney-
Gen Consortium; CKDGen Consortium; GUGC consortium.
(2012). Meta-analysis identifies multiple loci associated with
kidney function-related traits in east Asian populations. Nat.
Genet. 44, 904–909.
45. Kato, N., Takeuchi, F., Tabara, Y., Kelly, T.N., Go, M.J., Sim, X.,
Tay, W.T., Chen, C.H., Zhang, Y., Yamamoto, K., et al. (2011).
Meta-analysis of genome-wide association studies identifies
common variants associated with blood pressure variation
in east Asians. Nat. Genet. 43, 531–538.
46. Khor, C.C., Chau, T.N., Pang, J., Davila, S., Long, H.T., Ong,
R.T., Dunstan, S.J., Wills, B., Farrar, J., Van Tram, T., et al.
(2011). Genome-wide association study identifies suscepti-
bility loci for dengue shock syndrome at MICB and PLCE1.
Nat. Genet. 43, 1139–1141.013
